Details for Switzerland Supplementary Protection Certificate: C01539200/01
✉ Email this page to a colleague
Switzerland Supplementary Protection Certificate: C01539200/01
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1539200 | C01539200/01 | Switzerland | PRODUCT NAME: DACLIZUMAB BETA; REGISTRATION NO/DATE: AUTORISATION SWISSMEDIC 66069 26.01.2017 | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |